← Open Payments lookup

RACHEL GALLAGHER: Open Payments

NPI 1841851409 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,266 in 114 payments from 21 companies in 2025. Trend: 2023 $1,387 · 2024 $1,630 · 2025 $2,266

Food & beverage: $2,266
CompanyPaymentsAmount
ABBVIE INC.34$598
Takeda Pharmaceuticals U.S.A., Inc.11$206
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$196
Janssen Biotech, Inc.10$196
Regeneron Healthcare Solutions, Inc.6$195
Ardelyx, Inc.10$173
Phathom Pharmaceuticals, Inc.7$115
Braintree Laboratories, Inc.5$96
PFIZER INC.4$76
Lilly USA, LLC2$52

Products named: RINVOQ, DUPIXENT, XIFAXAN, TREMFYA, IBSRELA, ENTYVIO, VOQUEZNA, LINZESS.

Industry payments across IN — which companies pay providers there.